Table 1.
Baseline characteristics of the studied cohort with haematochemical parameters.
| n = (%) | Group 1 | Group 2 | Group 3 | Group 4 | Group 5 | ||
|---|---|---|---|---|---|---|---|
| Age | <40 | 40-64 | 65-89 | 90-94 | ≥95 | ||
| n = (%) | 154 | 29 (19%) | 39 (25%) | 50 (32%) | 12 (8%) | 24 (16%) | |
|
| |||||||
| Gender | M | 72 (47%) | 13 (45%) | 19 (49%) | 28 (56%) | 6 (50%) | 6 (25%) |
| F | 82 (53%) | 16 (55%) | 20 (51%) | 22 (44%) | 6 (50%) | 18 (75%) | |
|
| |||||||
| CRP | <5 g/dL | 127 (82%) | 26 (90%) | 34 (87%) | 43 (86%) | 6 (50%) | 18 (75%) |
| ≥5 g/dL | 27 (18%) | 3 (10%) | 5 (13%) | 7 (14%) | 6 (50%) | 6 (25%) | |
|
| |||||||
| UA | <2.4 g/dL | 15 (10%) | 4 (14%) | 4 (10%) | 1 (2%) | 3 (25%) | 3 (12%) |
| 2.4-7 g/dL | 114 (74%) | 23 (79%) | 33 (85%) | 37 (74%) | 3 (25%) | 18 (75%) | |
| >7 g/dL | 25 (16%) | 2 (7%) | 2 (5%) | 12 (24%) | 6 (50%) | 3 (13%) | |
|
| |||||||
| CHO | <200 g/dL | 113 (73%) | 27 (93%) | 22 (56%) | 35 (70%) | 10 (83%) | 19 (79%) |
| ≥200 g/dL | 41 (27%) | 2 (7%) | 17 (44%) | 15 (30%) | 2 (17%) | 5 (21%) | |
|
| |||||||
| LDL | <70 g/dL | 15 (10%) | 5 (17%) | 0 (0%) | 4 (8%) | 2 (17%) | 4 (17%) |
| 70-129 g/dL | 106 (69%) | 23 (79%) | 23 (59%) | 34 (68%) | 8 (66%) | 18 (75%) | |
| >70 g/dL | 33 (21%) | 1 (4%) | 16 (41%) | 12 (24%) | 2 (17%) | 2 (8%) | |